A recent study that found there has been a massive increase in type 2 diabetes cases worldwide since 1990 is an indication ...

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

All three pharmaceutical companies have established access schemes to provide insulin at lower cost to diabetics in poorer ...

The decision by Novo Nordisk to discontinue the insulin pens will force patients to revert to syringes, complicating diabetes care for millions of people.

Biomedical scientist Dr Judey Pretorius explains the close link between diabetes and skin problems. She says high blood sugar ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

Bhubaneswar: The Indian Army major and his betrothed, who were allegedly harassed by a group of youths and then subjected to custodial torture at Bharatpur police station on Sept 15, appeared before ...

Denmark is at the forefront of integrating artificial intelligence within structured regulation, recently launching a new AI ...

As Ozempic and other GLP-1 drugs explode in popularity, driven by their off-label use for rapid weight loss and viral social media trends, the pharmaceutical industry faces unprecedented challenges.